Unleash Immuno Oncolytics, Inc. reported raising $3 Million in an initial SEC Form D filing, from an offering of $3 Million
Amount Raised
$3 Million
Round Type
Seed
St. LouisBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Unleash Immuno Oncolytics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Praxis Precision Medicines, Inc. raised $19M on March 26, 2018.
- Cerecin raised $18M on March 26, 2018.
- Purple Biotech raised an undisclosed amount on March 26, 2018.
- IVIVA Medical, Inc. raised an undisclosed amount on March 26, 2018.
- OXOS Medical raised $100K (Seed) on March 26, 2018.
- SRX Global Inc. raised $777K (Seed) on March 26, 2018.
Who to call at Unleash Immuno Oncolytics, Inc., and when
A new round usually means Unleash Immuno Oncolytics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Unleash Immuno Oncolytics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Unleash Immuno Oncolytics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Unleash Immuno Oncolytics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Unleash Immuno Oncolytics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Unleash Immuno Oncolytics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.